Medicine Delivery Complaints Rise in Balochistan

Here’s a breakdown ⁣of the key data ⁣from the provided text, focusing on the core issue and supporting details:

Main Issue:

Patients in Colombia are facing significant difficulties accessing necessary prescription medications through their new EPS (health ⁣insurance providers) due to shortages. This is disrupting‍ treatments and forcing patients to purchase medications ⁤out-of-pocket.

Supporting Details:

Specific Examples:
‍ carlos Martínez received only‍ 2 out of 5 prescribed medications ⁣for his wife.
Luis Hernández has been waiting for 5 medications for three⁤ months, and is only being given ⁢cheaper alternatives.He spends approximately 200,000 pesos⁤ (Colombian currency) to⁤ buy the missing medications.
Ronaldo Escobar struggles to obtain his grandmother’s arthritis/osteoarthritis medications, often being told they are discontinued.
Impact on Patients:
Disrupted ⁢treatments.
Financial burden of ⁣purchasing medications⁤ privately.
Concern about the effectiveness of treatment if medications are unavailable.
* Government Intervention: The Superintendence of⁤ Industry and‍ Commerce (SIC) is involved⁣ in negotiating medicine prices with laboratories⁣ and the 9 EPS ⁢under⁣ government intervention. (The text ends mid-sentence, so the full context of this intervention is ‍unclear).In essence, the article highlights a growing healthcare crisis in Colombia where patients are unable to reliably access‍ the medications they need, despite⁣ being covered by health insurance.